Kynikos Associates President Jim Chanos discusses his short position in SolarCity, which oil companies he’s most confidently betting against, and what he finds most shocking about the embattled drugmaker Valeant Pharmaceuticals.
Kynikos Associates President Jim Chanos details the strategy behind his short position in SolarCity, and why he is betting against leveraged oil companies.
Thursday, 17 December 2015 4:12 PM ET
Kynikos Associates President Jim Chanos weighs in on Valeant and why it is wise to remain short the embattled drugmaker.
